Technology
Health
Biotechnology

uniQure

$65.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.64 (-0.96%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell uniQure and other stocks, options, ETFs, and crypto commission-free!

About

uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. Read More The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.

Employees
212
Headquarters
Amsterdam, Noord-Holland
Founded
1998
Market Cap
2.48B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
394.64K
High Today
$67.24
Low Today
$64.02
Open Price
$65.29
Volume
226.83K
52 Week High
$67.93
52 Week Low
$21.57

Collections

Technology
Health
Biotechnology
Gene Therapies
2014 IPO
Europe (Non-UK)
Europe

News

MarketBeatMar 2

Stock Price, News, & Analysis for Uniqure

News articles about QURE stock have been trending positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Uniqure earned a daily sentiment score of 2.2 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 5.0...

132
Guru FocusMar 1

uniQure to Participate in Multiple Upcoming Industry Conferences

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 01, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. ( QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it will participate in the following upcoming conferences in March: Leerink Global Health Care Conference in New York City Matt Kapusta , chief executive officer at uniQure, will participate in a fireside chat on Friday, March 1 at 9:30 a.m. ET. The live webcast can be acces...

129

Earnings

-$0.91
-$0.74
-$0.57
-$0.40
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 30, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.